Alzheimer's and Dementia


Webinar - English

Effects of Cannabis for People Living with Alzheimer’s Disease

Click to Register
You will be redirected back to this page after logging in or signing up as a member.

Medicinal cannabis is well-known for its pain-relieving properties, but how does it relate to Alzheimer’s disease?

Now that the recreational use of cannabis is legal in Canada, we must ask ourselves some questions: What effects could this have for people living with Alzheimer’s disease or related forms of dementia? Can cannabis be used to slow the progression of the disease? What are the long-term effects of cannabis use?

In this webinar, we will answer many of these questions and also dispel a number of myths.

The following topics will be discussed during the presentation:

  • the new federal and provincial law;
  • what are the potential effects on people living with Alzheimer’s disease and dementia;
  • how can cannabis be used to slow the progression of the disease;
  • what are the short and long-term effects of cannabis.

There will be a question period at the end of the presentation.

  1. Dr. Ben Gaied holds a PhD in molecular organic chemistry from the University of Strasbourg (France) and has completed a postdoctoral training at the University of Southampton (Southampton – UK). In 2013 Dr. Ben Gaied moved to Quebec and joined the Federation of Quebec Alzheimer Societies as director of communication and business development. Since July 2016, she’s the Director of research and Development, with the role of promoting the Alzheimer Society's research program, knowledge transfer and translation as well as insuring the quality of programs and services delivered. Dr. Ben Gaied is the author of several scientific papers and sits on various ministerial committees dedicated to the Alzheimer's plan, the use of antipsychotics in long term care, as well as the governance committee of the Consortium on early identification of Alzheimer's disease.